European Journal of Radiology
Volume 75, Issue 2 , Pages 143-146 , August 2010

Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT

  • Takami Kasai

      Affiliations

    • Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba-ken 260-8677, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 43 222 7171; fax: +81 43 226 2101.
  • ,
  • Ken Motoori

      Affiliations

    • Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba-ken 260-8677, Japan
    • Tel.: +81 43 222 7171; fax: +81 43 226 2101.
  • ,
  • Takuro Horikoshi

      Affiliations

    • Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba-ken 260-8677, Japan
    • Tel.: +81 43 222 7171; fax: +81 43 226 2101.
  • ,
  • Katsuhiro Uchiyama

      Affiliations

    • Diagnostic PET Imaging Center, Department of Radiology, Sannoh Medical Center, 166-2 Sannohcho, Inage-ku, Chiba City, Chiba-ken 263-0002, Japan
    • Tel.: +81 43 421 5660; fax: +81 43 421 6581.
  • ,
  • Kazuhiro Yasufuku

      Affiliations

    • Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba-ken 260-8670, Japan
    • Tel.: +81 43 222 7171; fax: +81 43 226 2172.
  • ,
  • Yuichi Takiguchi

      Affiliations

    • Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba-ken 260-8670, Japan
    • Tel.: +81 43 222 7171; fax: +81 43 226 2176.
  • ,
  • Fumiaki Takahashi

      Affiliations

    • Division of Biostatistics, Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
    • Tel.: +81 3 5791 6322; fax: +81 3 3444 2546.
  • ,
  • Yoshio Kuniyasu

      Affiliations

    • Diagnostic PET Imaging Center, Department of Radiology, Sannoh Medical Center, 166-2 Sannohcho, Inage-ku, Chiba City, Chiba-ken 263-0002, Japan
    • Tel.: +81 43 421 5660; fax: +81 43 421 6581.
  • ,
  • Hisao Ito

      Affiliations

    • Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba-ken 260-8677, Japan
    • Tel.: +81 43 222 7171; fax: +81 43 226 2101.

Received 28 October 2008 ,Accepted 14 April 2009.

References 

  1. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182:319–323
  2. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178:705–713
  3. Tahara RW, Lackner RP, Graver LM. Is there a role for routine mediastinoscopy in patients with peripheral T1 lung cancers?. Am J Surg. 2000;180:488–492
  4. Yasufuku K, Nakajima T, Motoori K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest. 2006;130:710–718
  5. Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg. 1995;110:130–139
  6. Lardinois D, Weber W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Eng J Med. 2003;348:2500–2507
  7. Kang WJ, Chung JK, So Y, Jeong JM, Lee DS, Lee MC. Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours. Eur J Nucl Med Mol Imaging. 2004;31:202–207
  8. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol. 1998;16(6):2142–2149
  9. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871–875
  10. Demura Y, Tsuchida T, Ishizaki T, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540–548
  11. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723
  12. Xiu Y, Bhutani C, Dhurairaj T, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32(2):101–105
  13. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-d-glucose. J Nucl Med. 1978;19:1154–1161
  14. Kubota K, Itoh M, Ozaki K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696–703
  15. Dobert N, Hamscho N, Menzel C, Neuss L, Kovacs AF, Grunwald F. Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesions. Nuklearmedizin. 2004;43:143–149
  16. Yen TC, Chang YC, Chan SC, et al. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?. Eur J Nucl Med Mol Imaging. 2005;32(5):541–548
  17. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med. 1999;26:1345–1348
  18. Nakamoto Y, Higashi T, Sakahara H, et al. Delayed 18F-fluoro-2-deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer. 2000;89:2547–2554

PII: S0720-048X(09)00227-7

doi: 10.1016/j.ejrad.2009.04.044

European Journal of Radiology
Volume 75, Issue 2 , Pages 143-146 , August 2010